Sodium-Glucose Cotransporter 2 Inhibitors: An Overview

Essie Samuel, PharmD, BCPS; Jiehyun Lee, PharmD, BCACP, CACP

Disclosures

US Pharmacist. 2017;42(10):42-47. 

In This Article

Counseling

Patients should be counseled to report symptoms of ketoacidosis, hypotension, UTI, and genital mycotic infections. Clinicians should advise patients to maintain adequate fluid intake because decreased oral intake or increased loss of fluids can potentially lead to AKI. In addition, patients must be informed of common side effects, such as increased urination, increased thirst, nausea, and constipation. Patients taking SGLT2 inhibitors, especially canagliflozin, should be advised to inform their providers of any new pain, sores, ulcers, or infections affecting their legs or feet.[4,19,20]

processing....